Novo Nordisk's pricing methods inside the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of price gouging, stating the stark contrast in between U.S. rates and those in Europe and copyright. Research of Rybelsus and copyright have proven t